Merck (MRK) Reiterated at Neutral by Cantor Fitzgerald
September 22, 2026 7:43 AM
Cantor Fitzgerald analyst Carter Gould reiterated a Neutral rating and $120.00 price target on Merck (NYSE: MRK).The analyst commented, "INTerpath-001 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
